THPO and type 2 diabetes mellitus: Due to the decreasing number of follow-ups, a more robust statistical method not sensitive to the loss of follow-up had to be chosen; therefore, it was investigated via age-corrected and stage-corrected linear mixed effect interaction models as to how T2DM and worse clinical outcome (death) affect the changes of platelet count, interleukin-6, and thrombopoietin levels with the course of the disease.